厄贝沙坦治疗充血性心力衰竭的临床观察
【摘要】目的:观察厄贝沙坦治疗充血性心力衰竭(CHF)的临床疗效。方法:36例经常规洋地黄、利尿剂、血管扩张剂等治疗效果欠佳的CHF患者,给予口服厄贝沙坦75~150 mg/d,治疗4~6周。观察治疗前后心率、心胸比、血压、左室射血分数变化。结果:治疗后心率、血压、心胸比与治疗前比较明显下降(P<0.01)﹐左室射血分数增加(P<0.01),心功能改善Ⅰ~Ⅱ级。药物不良反应少,患者耐受性好。结论:厄贝沙坦治疗CHF疗效好,不良反应较少,是CHF治疗的有效药物。
【关键词】心力衰竭;厄贝沙坦;血管紧张素Ⅱ
文章编号:1009-5519(2007)15-2235-02 中图分类号:R5 文献标识码:A
Study on the efficacy of irbesartan in the treatment of congestive heart failure
HUANG Xiao-yu,LU Heng
(The People's Hospital of Yangjiang,Guangdong 529500,China)
【Abstract】Objective:To observe the effect of irbesartan in treating the patients with congestive heart failure. Methods:Thirty-six patients Who had unsatisfactory results under conventional digitals ......
您现在查看是摘要页,全文长 5043 字符。